<DOC>
	<DOCNO>NCT03011645</DOCNO>
	<brief_summary>The purpose study identify gene variant increase risk cardiovascular disease ( CVD ) type 2 diabetes , particularly gene related stress factor .</brief_summary>
	<brief_title>Gene-by-Stress Interactions Intervention Studies Significance</brief_title>
	<detailed_description>In Aim 3 , 100 subject participate previous study recruit test ability 5HTR2C agonist ( lorcaserin ) increase antagonist ( ziprasidone ) reduce cortisol response mental metabolic stress men carry rs6318 C allele woman rs6318 CC genotype 5HTR2C . Lorcaserin serotonin receptor agonist indicate use weight loss drug . Ziprasidone antipsychotic indicate treatment bipolar disorder . Subjects treat single dose drug , 1 2 week apart , follow mental stress test oral glucose tolerance test multiple blood draw . Each subject also receive placebo drug one study visit .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<criteria>Men woman enrol STRRIDE , ENHANCED , and/or REMIT study age 18 year great . Ability willingness provide inform consent . Individuals specific genotype determine previous work sample Aim 1 project . Women know pregnant , intend become pregnant , breastfeed exclude . Women child bear potential ( age 55 ) inform need urine test pregnancy participate research willing Investigators provide information positive pregnancy test result . Subjects informed pregnancy test perform clinical purpose test substitute regular medical care need know whether may pregnant . History Type II diabetes mellitus . History prolong QT interval . Participation investigational drug trial within last 30 day . Already take either ziprasidone lorcaserin potential confounding medication , example , weight loss medication psychotropic medication . Unwillingness fast least 6 hour prior research study visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>